Observational study on patients with nonalcoholic fatty liver disease
Study on the Characteristic, Therapy and Prognosis of Patients With Nonalcoholic Fatty Liver Disease
This study looks at patients with nonalcoholic fatty liver disease to see how their condition varies and to collect samples for future research.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Trial ID | NCT05625750 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients diagnosed with nonalcoholic fatty liver disease (NAFLD) and aims to categorize them into NAFLD and nonalcoholic steatohepatitis (NASH) groups. Researchers will collect various clinical examination indexes, including liver enzyme levels and triglyceride content, to assess the condition and prognosis of the patients. Additionally, biological samples such as serum, feces, urine, and liver tissue will be collected for future testing. The study does not involve any additional interventions or treatments for the participants.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with nonalcoholic fatty liver disease.
Not a fit: Patients with excessive alcohol consumption or other serious health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to a better understanding of NAFLD and inform the development of effective therapies.
How similar studies have performed: Other studies have explored NAFLD, but this observational approach focusing on detailed clinical indexes and sample collection is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. patients diagnosed with nonalcoholic fatty liver disease Exclusion Criteria: 1. patients suspected of excessive alcohol consumption 2. malignant tumors, dementia, active tuberculosis, AIDS, organ failure, pregnancy or breastfeeding, etc cannot cooperate with the investigation 3. incomplete data such as HBV serological results and abdominal ultrasound results 4. patients who refuse to sign informed consent
Where this trial is running
Changsha, Hunan
- Department of Infectious Disease, Xiangya Hospital, Central South University — Changsha, Hunan, China (Recruiting)
Study contacts
- Study coordinator: Yan Huang
- Email: ganrankedrhyan@163.com
- Phone: +86 13874854142
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.